Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter

Quantitative susceptibility mapping (QSM) measures bulk susceptibilities in the brain, which can arise from many sources. In iron-rich subcortical gray matter (GM), non-heme iron is a dominant susceptibility source. We evaluated the use of QSM for iron mapping in subcortical GM by direct comparison to tissue iron staining. We performed in situ or in vivo QSM at 4.7 T combined with Perls' ferric iron staining on the corresponding extracted subcortical GM regions. This histochemical process enabled examination of ferric iron in complete slices that could be related to susceptibility measurements. Correlation analyses were performed on an individual-by-individual basis and high linear correlations between susceptibility and Perls' iron stain were found for the three multiple sclerosis (MS) subjects studied (R(2) = 0.75, 0.62, 0.86). In addition, high linear correlations between susceptibility and transverse relaxation rate (R2*) were found (R(2) = 0.88, 0.88, 0.87) which matched in vivo healthy subjects (R(2) = 0.87). This work validates the accuracy of QSM for brain iron mapping and also confirms ferric iron as the dominant susceptibility source in subcortical GM, by demonstrating high linear correlation of QSM to Perls' ferric iron staining.

[1]  Maria Grazia Bruzzone,et al.  Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. , 2009, Radiology.

[2]  J. Reichenbach,et al.  Magnetic susceptibility-weighted MR phase imaging of the human brain. , 2005, AJNR. American journal of neuroradiology.

[3]  S Ropele,et al.  Determinants of brain iron in multiple sclerosis , 2011, Neurology.

[4]  R A Brooks,et al.  Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. , 1990, Radiology.

[5]  Saifeng Liu,et al.  Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging , 2013, NeuroImage.

[6]  David A Bennett,et al.  Postmortem MRI of human brain hemispheres: T2 relaxation times during formaldehyde fixation , 2009, Magnetic resonance in medicine.

[7]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[8]  J. Schenck,et al.  High‐field magnetic resonance imaging of brain iron: birth of a biomarker? , 2004, NMR in biomedicine.

[9]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[10]  Yi Wang,et al.  Calculation of susceptibility through multiple orientation sampling (COSMOS): A method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI , 2009, Magnetic resonance in medicine.

[11]  Rolf Gruetter,et al.  On the origin of the MR image phase contrast: An in vivo MR microscopy study of the rat brain at 14.1 T , 2009, NeuroImage.

[12]  Chunlei Liu,et al.  Whole brain susceptibility mapping using compressed sensing , 2012, Magnetic resonance in medicine.

[13]  D. Land,et al.  Multiple-probe thermography for estimating the postmortem interval: II. Practical versions of the Triple-Exponential Formulae (TEF) for estimating the time of death in the field. , 2001, Journal of forensic sciences.

[14]  Siegfried Trattnig,et al.  Combining phase images from multi‐channel RF coils using 3D phase offset maps derived from a dual‐echo scan , 2011, Magnetic resonance in medicine.

[15]  Yi Wang,et al.  Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging , 2010, Magnetic resonance in medicine.

[16]  Yu-Chung N. Cheng,et al.  Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.

[17]  Patrice Péran,et al.  Voxel‐based analysis of R2* maps in the healthy human brain , 2007, Journal of magnetic resonance imaging : JMRI.

[18]  P. Burger,et al.  MR detection of brain iron. , 1993, AJNR. American journal of neuroradiology.

[19]  Ferdinand Schweser,et al.  Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study , 2012, NeuroImage.

[20]  Torsten Rohlfing,et al.  MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping , 2011, NeuroImage.

[21]  John S Leigh,et al.  Quantifying arbitrary magnetic susceptibility distributions with MR , 2004, Magnetic resonance in medicine.

[22]  Jeff H. Duyn,et al.  High-field MRI of brain cortical substructure based on signal phase , 2007, Proceedings of the National Academy of Sciences.

[23]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[24]  J. Duyn,et al.  Characterization of T2* heterogeneity in human brain white matter , 2009, Magnetic resonance in medicine.

[25]  G A Johnson,et al.  MRI of brain iron. , 1986, AJR. American journal of roentgenology.

[26]  Jürgen R. Reichenbach,et al.  The future of susceptibility contrast for assessment of anatomy and function , 2012, NeuroImage.

[27]  Ferdinand Schweser,et al.  Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? , 2011, NeuroImage.

[28]  Bing Wu,et al.  Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition , 2011, NeuroImage.

[29]  J W Langston,et al.  The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. , 1999, Magnetic resonance imaging.

[30]  Louise van der Weerd,et al.  MRI artifacts in human brain tissue after prolonged formalin storage , 2011, Magnetic resonance in medicine.

[31]  C D Marsden,et al.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.

[32]  R. Marc Lebel,et al.  Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis , 2012, Multiple sclerosis.

[33]  Richard Bowtell,et al.  Whole-brain susceptibility mapping at high field: A comparison of multiple- and single-orientation methods , 2010, NeuroImage.

[34]  Mark Jenkinson,et al.  Fast, automated, N‐dimensional phase‐unwrapping algorithm , 2003, Magnetic resonance in medicine.

[35]  S. Ropele,et al.  Quantitative MR imaging of brain iron: a postmortem validation study. , 2010, Radiology.

[36]  J. R. Mitchell,et al.  Deep grey matter `black T2` on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis , 2007, Multiple sclerosis.

[37]  Jeff F. Dunn,et al.  Iron in multiple sclerosis: roles in neurodegeneration and repair , 2014, Nature Reviews Neurology.

[38]  Carlo Ciulla,et al.  Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain , 2007, Journal of magnetic resonance imaging : JMRI.

[39]  Pascal Spincemaille,et al.  Nonlinear Regularization for Per Voxel Estimation of Magnetic Susceptibility Distributions From MRI Field Maps , 2010, IEEE Transactions on Medical Imaging.

[40]  Steven M LeVine,et al.  Pathogenic implications of iron accumulation in multiple sclerosis , 2012, Journal of neurochemistry.

[41]  Jeff H. Duyn,et al.  Susceptibility contrast in high field MRI of human brain as a function of tissue iron content , 2009, NeuroImage.

[42]  A. Wilman,et al.  Background field removal using spherical mean value filtering and Tikhonov regularization , 2014, Magnetic resonance in medicine.

[43]  Silvia Mangia,et al.  Toward understanding transverse relaxation in human brain through its field dependence , 2012, Magnetic resonance in medicine.

[44]  R Marc Lebel,et al.  Multiple sclerosis: validation of MR imaging for quantification and detection of iron. , 2013, Radiology.

[45]  R A Knight,et al.  MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. , 1999, Radiology.

[46]  Reiko Meguro,et al.  Nonheme-iron histochemistry for light and electron microscopy: a historical, theoretical and technical review. , 2007, Archives of histology and cytology.

[47]  Daniela Berg,et al.  Role of Iron in Neurodegenerative Disorders , 2006, Topics in magnetic resonance imaging : TMRI.

[48]  Yi Wang,et al.  Morphology enabled dipole inversion (MEDI) from a single‐angle acquisition: Comparison with COSMOS in human brain imaging , 2011, Magnetic resonance in medicine.

[49]  R M Henkelman,et al.  MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. , 1993, AJNR. American journal of neuroradiology.

[50]  Christian Langkammer,et al.  Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan , 2014, Human brain mapping.

[51]  J. Duyn,et al.  Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data , 2009, Magnetic resonance in medicine.

[52]  Andrea Cherubini,et al.  Aging of subcortical nuclei: Microstructural, mineralization and atrophy modifications measured in vivo using MRI , 2009, NeuroImage.

[53]  Christian Langkammer,et al.  Iron mapping using the temperature dependency of the magnetic susceptibility , 2015, Magnetic resonance in medicine.

[54]  Steven M LeVine,et al.  Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.